Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sunovion Pharmaceuticals

Sunovion Pharmaceuticals

Developer of innovative therapies designed to broadly contribute to society through value creation based on innovative research and development activities for the betterment of health care. The company's innovative therapies addresses serious psychiatric, neurological and respiratory conditions, enabling people with serious medical conditions lead fulfilling lives.

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • 84 Waterford Drive
  • Marlborough, MA 01752
  • United States

+1 (508) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sunovion Pharmaceuticals’s full profile, request a free trial.

Sunovion Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Oct-2009 $2.86B 00.000 Completed Generating Revenue
2. IPO 20-Sep-1991 Completed Generating Revenue
1. Early Stage VC 01-Jan-1985 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sunovion Pharmaceuticals Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Janssen Research and Development Corporate Backed or Acquired Titusville, NJ 000000&0
00000000 Corporation Valby, Denmark 0000
000000 000000 Corporate Backed or Acquired Stamford, CT 000 000000&0
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
0000000 000000 Corporation Tokyo, Japan 00000 000000&0
To view this company’s complete list of competitors, request access »

Sunovion Pharmaceuticals Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 21-Oct-2016 000000000000000000 00000 Pharmaceuticals 00000000 000000
00000000 000000000 05-Sep-2012 000000000000000000 00000 Therapeutic Devices 0000000 000000
00000000 000000000 04-Jun-2008 000000000000000000 000.00 Pharmaceuticals 000000 00000
000000 00000000000 17-Jan-2006 0000 0000 Pharmaceuticals 0000000 000000000
ACADIA Pharmaceuticals 11-Jan-2005 PIPE 0000 Pharmaceuticals 0000000 000000000
To view this company’s complete investment and acquisition history, request access »

Sunovion Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 17-Jan-2006 0000 0000 Completed
  • 00000000 000000000
ACADIA Pharmaceuticals 11-Jan-2005 PIPE 0000 Completed
To view this company’s complete exits history, request access »

Sunovion Pharmaceuticals Executive Team (6)

Name Title Board
Nobuhiko Tamura Chairman & Chief Executive Officer
Stephen Freeman Senior Vice President & Chief Financial Officer
Shinichiro Katayanagi Executive Vice President, Corporate Development and Licensing
Antony Loebel Executive Vice President, Chief Medical Officer and Head of Global Clinical Development
Christine Foster Ph.D Head of Search and Evaluation, Corporate Development and Licensing

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Sunovion Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Hiroshi Nomura Sunovion Pharmaceuticals Vice Chairman 000 0000
Nobuhiko Tamura Sunovion Pharmaceuticals Chairman & Chief Executive Officer 000 0000

2 Former Board Members

You’re viewing 2 of 4 board members. Get the full list »